Cite
HARVARD Citation
Elshami, M. et al. (2022). A nationwide analysis of clinical trial participation for common hepato-pancreato-biliary malignancies demonstrates survival advantages for subsets of trial patients but disparities in and infrequency of enrollment. HPB. 24 (8), pp. 1280-1290. [Online].